IQVIA™ Pharma Deals: PharmaDeals Review: Table of Contents

<< Previous Issue

Apr 2017 (Vol: 2017, Issue: 4)

Next Issue >>

Section: Licensing
Neurocrine gains BIAL’s Parkinson’s asset Opicapone for North America Published: 5 Apr-2017
By: Vipul Sikka
Abstract Fulltext:
BMS Expands Collaboration with CytomX for US$200 M Upfront Published: 8 Apr-2017
By: Natasha Piper
Abstract Fulltext:
AstraZeneca Out-licenses US Rights for its COPD Drugs to Circassia Published: 22 Apr-2017
By: Jasmine Kalsi
Abstract Fulltext:
Section: Mergers & Acquisitions
Otsuka Gains Late-Stage ADHD Drug in Neurovance Acquisition Published: 6 Apr-2017
By: Natasha Piper
Abstract Fulltext:
Astellas Acquires Fezolinetant for Menopausal Symptoms in Ogeda Acquisition Published: 20 Apr-2017
By: Natasha Piper
Abstract Fulltext:

PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.

Login

Username:

Password:

Keep me logged in